AssetID: 54782568
Headline: UNCAPTIONED: FDA May Restrict Future Covid-19 Vaccines to Older and High-Risk Groups
Caption: FDA May Restrict Future Covid-19 Vaccines to Older and High-Risk Groups. The US Food and Drug Administration is considering limiting future Covid-19 vaccine approvals to adults aged 65 and older, and those with underlying health conditions that increase their risk of severe infection. This shift reflects new guidelines on the type of evidence manufacturers must provide for updated vaccines. FDA officials Vinay Prasad and Marty Makary explained in a recent editorial that these changes, aligning the US with countries like the UK and Canada, may mean many healthy adults and children could lose access to updated shots. They argue there’s insufficient proof that routine vaccination benefits healthy people, particularly those aged 50 to 64, and want more placebo-controlled trials before expanding eligibility. Whether vaccine makers like Pfizer and Moderna will conduct these expensive and lengthy studies remains uncertain. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,FDA,restrict,future,Covid-19,vaccines,older,high-risk,groups,new guidelines,type of evidence,manufacturers,Pfizer,updated,top up,UK,Canada,officials,Vinay Prasad,Marty Makary,insufficient proof,routine,benefits,healthy people,shots,children,lose access
PersonInImage: